Bolt Biotherapeutics
Brian O’Callaghan is the current Director at Bolt Biotherapeutics. Prior to this, they were the President & CEO and Chairman of the Board of Directors at Sonrgy, Inc. from May 2015 to April 2017. Brian was also the President & CEO and a member of the Board of Directors at Acucela Inc. from September 2013 to May 2015. Brian has also held positions at BIOCOM PURCHASING GROUP, INC., Aquavit Pharmaceuticals, Inc., and Decoy Biosystems. Brian was the Chief Executive Officer at Petra Pharma Corporation from May 2017 to May 2020 and the President & CEO as well as a member of the Board of Directors at Sangart from June 2008 to January 2014.
Brian O'Callaghan has a Master of Business Administration (MBA) from Henley Business School, a Diploma from The Marketing Institute of Ireland, and another MBA from the University of Reading.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Bolt Biotherapeutics
7 followers
Bolt Biotherapeutics, Inc., based in the San Francisco Bay Area, is a publicly-traded biotechnology company developing Boltbody™ Immune-stimulating Antibody Conjugates (ISAC), a new class of immuno-oncology therapeutics that have eliminated tumors following systemic administration in preclinical studies and results in the development of immunological memory, which may lead to more durable clinical responses for patients.